Literature DB >> 6221841

Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barré syndrome).

R A Hughes, S Aslan, I A Gray.   

Abstract

Ficoll-Triosil separated peripheral blood mononuclear (PBM) cells were analysed by fluorescent microscopy with Ortho monoclonal antisera to T cells (OKT3+) helper cells (OKT4+) and suppressor cytotoxic cells (OKT8+) and with polyclonal antiserum to surface immunoglobulin. Twenty-five normal subjects, 16 patients with acute polyradiculoneuritis (Guillain-Barré syndrome, AP) and 10 patients with other neurological diseases were studied. The percentages of OKT3+, OKT4+ and immunoglobulin bearing cells were similar in the three patient groups but the percentage of OKT8+ cells was reduced to 13.5 +/- 4.1 (mean +/- s.d.) compared with 19.4 +/- 4.9 in the normal subjects and 18.5 +/- 3.1 in the patients with other neurological diseases. The ratio of OKT4+/OKT8+ cells was correspondingly increased to 3.5 +/- 2.1 compared with 2.1 +/- 0.5 in the normal subjects and 2.1 +/- 0.4 in the patients with other neurological diseases. In one test of suppressor cell function Con A incubated mitomycin treated PBM cells were added to autologous PBM cells stimulated with Con A to compare the degree of suppression with that produced by control incubated mitomycin treated cells (Con A suppression test). In a second test of suppressor cell function short lived suppressor cell (SLS) activity was assayed by comparing PBM stimulation by Con A added at the start of culture with that produced by Con A added after 24 hr. Neither test revealed any significant differences between AP patients and control subjects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221841      PMCID: PMC1536792     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Lymphocyte subpopulations in blood and cerebrospinal fluid from patients with acute Guillain-Barré syndrome.

Authors:  H Nyland; A Nacess
Journal:  Eur Neurol       Date:  1978       Impact factor: 1.710

2.  Abnormal T cell subpopulations and circulating immune complexes in the Guillain-Barré syndrome and multiple sclerosis.

Authors:  J M Goust; F Chenais; J E Carnes; C G Hames; H H Fudenberg; E L Hogan
Journal:  Neurology       Date:  1978-05       Impact factor: 9.910

3.  A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes.

Authors:  J Oger; S Szuchet; J Antel; B G Arnason
Journal:  Nature       Date:  1982-01-07       Impact factor: 49.962

4.  Relative ability to provide help: an explanation for Con A-induced suppression.

Authors:  J Farrant; C Newton
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

Review 5.  The use of concanavalin A to study the immunoregulation of human T cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

7.  Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein,P2.

Authors:  M Kadlubowski; R A Hughes; N A Gregson
Journal:  Brain Res       Date:  1980-02-24       Impact factor: 3.252

8.  Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies.

Authors:  N K Damle; S Gupta
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis.

Authors:  D H Crawford; P Brickell; N Tidman; I McConnell; A V Hoffbrand; G Janossy
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  9 in total

1.  A prospective study of acute idiopathic neuropathy. III. Immunological studies.

Authors:  J B Winer; I A Gray; N A Gregson; R A Hughes; S Leibowitz; P Shepherd; W A Taylor; V Yewdall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

2.  Acute inflammatory demyelinating polyradiculoneuropathy following varicella.

Authors:  J M Murthy
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

3.  Guillain-Barré syndrome in a patient with chronic lymphocytic leukaemia.

Authors:  M Jackson
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

4.  Circulating T cell subsets in the Lambert-Eaton myasthenic syndrome.

Authors:  S A Robb; T J Bowley; H N Willcox; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

5.  Acute Lagophthalmos due to Bell's Palsy could be a Sign of COVID-19.

Authors:  Ibrahim Ozdemir; Sucattin Ilker Kocamıs
Journal:  Neuroophthalmology       Date:  2021-06-11

Review 6.  Guillain-Barré syndrome after varicella-zoster infection. Report of two cases.

Authors:  E A Sanders; A C Peters; J W Gratana; R A Hughes
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

Review 7.  Guillain-Barré syndrome: clinical and immunological aspects.

Authors:  A M Rostami
Journal:  Springer Semin Immunopathol       Date:  1995

8.  Guillain-Barré syndrome in a patient with hairy cell leukaemia.

Authors:  S C Tayal; D S Rowbotham; S K Bansal
Journal:  J R Soc Med       Date:  1991-04       Impact factor: 18.000

9.  Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin.

Authors:  Hui Qing Hou; Jun Miao; Xue Dan Feng; Mei Han; Xiu Juan Song; Li Guo
Journal:  BMC Neurol       Date:  2014-10-15       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.